$0.0002
+0 (+0%)
At Close: Jun 05, 2026
Clover Health to Participate in Upcoming Leerink 2026 Global Healthcare Conference
04:05pm, Tuesday, 17'th Feb 2026
WILMINGTON, Del., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover,” “Clover Health” or the “Company”), today announced that its Chief Financial O
ROCKVILLE, Md., Feb. 17, 2026 (GLOBE NEWSWIRE) -- NovaBridge Biosciences (Nasdaq: NBP) (NovaBridge or the Company) a global biotechnology platform company committed to accelerating access to innovativ
RB Global Reports Fourth Quarter and Full Year 2025 Results
04:01pm, Tuesday, 17'th Feb 2026
WESTCHESTER, Ill.--(BUSINESS WIRE)--RB Global, Inc. (NYSE & TSX: RBA, the “Company”, “RB Global”, “we”, “us”, “their”, or “our”) reported the following results for the three mo
Zeta Global: The Wrong SaaSpocalypse Victim
03:37pm, Tuesday, 17'th Feb 2026
Zeta Global Holdings Corp. is a Strong Buy ahead of Q4 earnings, with shares undervalued after an unjustified selloff. ZETA's hybrid, usage-based monetization model and AI-powered platform differentia
How This Global Small Cap ETF Fits Into a Long-Term Strategy
03:30pm, Tuesday, 17'th Feb 2026
The S&P 500 is easy for investors to access, but it's dominated by large-cap U.S. companies. An ideal complement to these holdings is the WisdomTree International SmallCap Dividend Fund.
Ralliant Corporation (RAL) Presents at Citi's Global Industrial Tech & Mobility Conference 2026 Transcript
02:24pm, Tuesday, 17'th Feb 2026
Ralliant Corporation (RAL) Presents at Citi's Global Industrial Tech & Mobility Conference 2026 Transcript
TeamBest Global President and Founder Dr. Krishnan Suthanthiran Addresses Canada, Enbridge CEO, and Investors
01:23pm, Tuesday, 17'th Feb 2026
WASHINGTON--(BUSINESS WIRE)--Dr. Suthanthiran owns the town of Kitsault, located northwest of Prince Rupert. Kitsault was originally developed as a mining community by Amax Canada Development Ltd. and
New analysis shows: Private Credit surging as a vital funding source, particularly for lower-rated borrowers facing significant refinancing needs through 2028. Primary bond markets' capacity to absorb
Investment Manager Downsizes Position in Global Electronics Supplier, According to Recent SEC Filing
11:35am, Tuesday, 17'th Feb 2026
Sold 20,392 Littelfuse shares; estimated transaction value ~$5.19 million (based on quarterly average price) Quarter-end position value decreased by $6.99 million, reflecting both trading activity and
ExOne Global Holdings Announces Board of Directors
09:00am, Tuesday, 17'th Feb 2026
GERSTHOFEN, Germany & WASHINGTON--(BUSINESS WIRE)--ExOne Global Holdings announced its Board of Directors, bringing together industrial technology operators, investors, & additive manufacturing leader
Palisade Bio Appoints Global IBD Precision Medicine Leader Bram Verstockt, MD, PhD to Clinical Advisory Board
08:45am, Tuesday, 17'th Feb 2026
Appointment strengthens Phase 2 development strategy for PALI-2108 in ulcerative colitis and fibrostenotic Crohn's disease; Phase 2 ulcerative colitis IND submission planned for first half of 2026
Booz Allen to Expand Global Commercial Business with Acquisition of Defy Security
08:30am, Tuesday, 17'th Feb 2026
MCLEAN, Va.--(BUSINESS WIRE)---- $BAH--Booz Allen (NYSE: BAH) today announced that it has entered into a definitive agreement to acquire Defy Security as a wholly owned subsidiary.
Payoneer to Launch Stablecoin Capabilities, Powered by Bridge, Bringing Secure, Always-On Digital Money to Global Businesses
08:30am, Tuesday, 17'th Feb 2026
NEW YORK, Feb. 17, 2026 /PRNewswire/ -- Payoneer (NASDAQ: PAYO), the global financial technology company powering business growth across borders, today announced plans to launch a suite of stablecoi
Verisk and S&P Global Energy Collaborate to Deliver Insurance-Adjusted Climate Risk Intelligence
08:30am, Tuesday, 17'th Feb 2026
Collaboration provides shared analytical foundation for helping to bridge the gap between sustainability, insurance and financial modeling for industries including banking, asset management, and real
Cellectar Biosciences Expands Global Intellectual Property Estate
08:05am, Tuesday, 17'th Feb 2026
Strengthens Protection Around Broad Portfolio of Cancer-Targeting Drug Conjugates and Enabling Technologies Provides Key Coverage Across Europe Ahead of Planned 3Q26 Filing for Conditional Marketing A
Sign In
Buy GTLL